HC Wainwright & Co. Maintains Buy on Icecure Medical, Raises Price Target to $2.5

Benzinga · 10/07/2025 10:44
HC Wainwright & Co. analyst Yi Chen maintains Icecure Medical (NASDAQ:ICCM) with a Buy and raises the price target from $2 to $2.5.